The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
Ying Taur(Memorial Sloan Kettering Cancer Center), Eric G. Pamer(University of Illinois Chicago), Marcel R.M. van den Brink(City Of Hope National Medical Center), Eric R. Littmann, Sejal Morjaria, Robert R. Jenq(City Of Hope National Medical Center), Parastoo B. Dahi(Memorial Sloan Kettering Cancer Center), Agnès Viale(Genomics (United Kingdom)), Doris M. Ponce(Memorial Sloan Kettering Cancer Center), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Juliet N. Barker(King's College London), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Lilan Ling(Memorial Sloan Kettering Cancer Center), Daniel J. No(Memorial Sloan Kettering Cancer Center), Asia Gobourne(Memorial Sloan Kettering Cancer Center)
Cited by 880
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k